GlaxoSmithKline
GSK
#188
Rank
A$135.16 B
Marketcap
$65.50
Share price
1.25%
Change (1 day)
20.58%
Change (1 year)

GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

Volume in USD (price x number of shares), data since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$40.87 M36.69%
2023A$29.9 M-43.98%
2022A$53.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
A$15.89 MA$0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.25 BA$0.52 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$41.29 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.2 MA$91.24 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$5.36 MA$73.72 M๐Ÿ‡ซ๐Ÿ‡ท France
A$12.13 MA$29.69 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$22.43 MA$24.63 M๐Ÿ‡บ๐Ÿ‡ธ USA